SCHEMBL4375945

SCHEMBL4375945

Cc1ccc2c(c1)c1c(n2C)C([Si](C)(C)Cl)c2ccccc2-1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NR1I2 O75469 1/20 0.39
AHR P35869 1/20 0.39
BCHE P06276 1/20 0.34
ACHE P22303 1/20 0.34
KDM4E B2RXH2 5/20 0.34
MAPT P10636 3/20 0.34
HTT P42858 2/20 0.34
APAF1 O14727 1/20 0.34
PKM P14618 1/20 0.34
IDO1 P14902 1/20 0.34
MAPK1 P28482 1/20 0.34
RAB9A P51151 1/20 0.34
MCL1 Q07820 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
HSD17B10 Q99714 3/20 0.33
NTRK1 P04629 1/20 0.33
USP2 O75604 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4383628 0.84 ALDH1A1 (0.46) MEN1KMT2ABCHEACHEKDM4E
SCHEMBL17842624 0.80 MEN1 (0.42) MEN1KMT2ANR1I2AHRBCHE
SCHEMBL7124338 0.78 MEN1 (0.39) MEN1KMT2ANR1I2AHRBCHE
SCHEMBL7636376 0.76 MEN1 (0.37) MEN1KMT2ANR1I2AHRBCHE
Hydrochloric Acid SCHEMBL7120127 0.75 MEN1 (0.36) MEN1KMT2ANR1I2AHRBCHE
Hydrochloric Acid SCHEMBL3923993 0.75 MEN1 (0.36) MEN1KMT2ANR1I2AHRBCHE
SCHEMBL7195665 0.74 GPR3 (0.40) KDM4EMAPTIDO1HSD17B10NTRK1
SCHEMBL4376916 0.74 ALDH1A1 (0.48) MEN1KMT2ABCHEACHEKDM4E
SCHEMBL7116380 0.74 DNMT1 (0.37) MEN1KMT2ARAB9AALDH1A1
SCHEMBL19996234 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1533324-B1 A ligand for a metallocene catalyst used to prepare propylene based polymers, and its preparation method BASELL POLYOLEFINE GMBH (DE) 2009-05-06 EP disclosed
EP-1533324-A2 A ligand for a metallocene catalyst used to prepare propylene based polymers, and its preparation method Basell Polyolefine GmbH (DE) 2005-05-25 EP disclosed
EP-1159310-B1 PROCESS FOR PRODUCING SUBSTANTIALLY AMORPHOUS PROPYLENE-BASED POLYMERS BASELL POLYOLEFINE GMBH (DE) 2005-03-30 EP disclosed
US-6730754-B2 COORDINATION POLYMERIZATION CATALYST BASELL POLYOLEFINE GMBH (DE) 2004-05-04 US disclosed
US-20020147286-A1 Process for producing substantially amorphous propylene-based polymers EQUISTAR CHEMICALS, LP 2002-10-10 US disclosed
EP-1159310-A1 PROCESS FOR PRODUCING SUBSTANTIALLY AMORPHOUS PROPYLENE-BASED POLYMERS Basell Technology Company B.V. (NL) 2001-12-05 EP disclosed
WO-2001053360-A1 PROCESS FOR PRODUCING SUBSTANTIALLY AMORPHOUS PROPYLENE-BASED POLYMERS BASELL TECHNOLOGY COMPANY B.V. (NL) 2001-07-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020147286-A1 Process for producing substantially amorphous propylene-based polymers GRB7, CHRM1, CPNE4 MEN1 2468/4885KMT2A 3512/4885NR1I2 539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.